There are no vaccination strategies against Helicobacter pylori, a gram-negative bacterium that colonizes the gastric mucosa. Eradication relies on antimicrobial therapy to reduce transmission, promote mucosal healing and reduce the risk of gastric cancer. Persistent Helicobacter pylori infectionafter failed eradication remains a major clinical challenge, especially in the face of increasing antibiotic resistance.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Digital dermatology: innovative project examples
AI and eHealth tools in HS care
- Mantle cell lymphoma
Recurrence after BTK inhibition – prognostic factors and treatment options
- Dementia risk with type 2 diabetes
SGLT2 inhibitors with advantages vs. DPP4 inhibitors
- T helper 1 cells
Differentiation and activation of Th1 cells – a multi-omics approach
- Cannabis for schizophrenia
CBD pre-treatment could exacerbate side effects
- Type 2 diabetes: cardiovascular risk reduction is realistic
Modern active ingredients and lifestyle – every step counts
- Case study
8-year-old girl with Pätau syndrome aka trisomy 13
- Lichen sclerosus